If glutathione (GSH) levels are low, these toxins are not efficiently removed from the body and can cause damage to cellular DNA, cell membranes, and mitochondria, which can result in an array of symptoms and disease, contribute to existing medical conditions (such as infertility), and cause problems with pregnancy and the future health of the offspring
Furthermore, the low hypoglycaemia risk associated with this combination enhances treatment safety and patient quality of life, avoiding the glucose fluctuations and weight gain often seen with insulin intensification
According to the FDA prescribing information, tirzepatide is associated with modest increases in heart rate (average 2-4 beats per minute), consistent with the class effect observed with GLP-1 receptor agonists
Always check the specific trial's eligibility criteria on ClinicalTrials.gov
Some people also report rashes, muscle pains, and diarrhea